Best Cannabis Stocks – Navigating the Highs and Lows of the 12 Leaders


In recent years, the best cannabis stocks have captivated the attention of investors worldwide, offering a new frontier in an ever-evolving market landscape. As more countries and states move towards the legalization of cannabis, both for medicinal and recreational use, the industry’s economic footprint continues to expand, presenting unique opportunities and challenges for traders and investors.

This blog post delves into the world of cannabis stocks, examining the tumultuous price movements of the past and providing a detailed overview of prominent companies within the sector. Whether you’re a seasoned investor or new to the stock market, understanding the dynamics of cannabis stocks is crucial for navigating this high-growth industry.

Best Cannabis Stocks

Understanding the Best Cannabis Stocks

Cannabis stocks represent companies involved in the legal production, distribution, or sale of cannabis and related products. These entities range from direct growers and retailers of cannabis to companies offering ancillary services like the development of specialized equipment and financial services.

The allure of cannabis stocks lies in the industry’s rapid growth and the significant consumer demand driving the market. However, due to varying regulatory landscapes across different regions, these stocks often face high volatility, making them an intriguing option for investors looking for potential high returns.

A Brief History of the best Cannabis Stocks

The journey of cannabis stocks on major stock exchanges began less than a decade ago but has been marked by significant milestones. Initially, these stocks were seen as speculative investments due to the legal uncertainties surrounding cannabis. However, major shifts began with legislative breakthroughs such as Colorado and Washington legalizing recreational cannabis in 2012, followed by Uruguay becoming the first country to fully legalize cannabis in 2013.

These events sparked interest and set the stage for a global shift in perception. In Canada, the legalization of cannabis in October 2018 marked a pivotal moment, leading to the establishment of publicly traded companies like Canopy Growth and Aurora, which became bellwethers for the industry. Despite these advancements, the road has been anything but smooth, with stock prices experiencing significant swings due to regulatory updates, market saturation, and shifting investor sentiment.

Turbulent Price Developments

The price volatility of cannabis stocks has been notable, characterized by sharp rises and sudden falls. This turbulence can often be attributed to several factors:

  • Regulatory changes: News of legalization in new areas can lead to price surges, while regulatory setbacks or stricter-than-anticipated regulations can cause declines.
  • Market speculation: The nascent and headline-driven nature of the market leads to speculative trading, where prices can spike on rumors and drop on news.
  • Global events: International incidents, such as the COVID-19 pandemic, have also influenced cannabis stocks, initially harming stock prices due to economic uncertainty but later seeing gains as demand for cannabis surged during lockdowns.

For example, in early 2019, many cannabis stocks reached their peak as enthusiasm about new markets opening up, like in Canada, drove investor optimism. However, the reality of oversupply, logistical challenges, and slower-than-expected retail openings led to a sharp correction in the months that followed. More recently, the industry has seen some stabilization and renewed investor interest as companies consolidate, improve their operational efficiencies, and expand into new markets with clearer regulatory frameworks. We are happy to present you with our pick of the best cannabis stocks.

Company Profiles

Canopy Growth

Overview: Canopy Growth Corporation is one of the largest cannabis companies globally, headquartered in Smiths Falls, Canada. It was one of the first companies to be publicly traded in the cannabis industry and has since expanded its operations to include various cannabis products, including recreational and medical marijuana.

Historical Stock Performance: Canopy Growth’s stock has seen significant volatility. It surged in 2018 following the legalization of cannabis in Canada but has faced challenges such as regulatory hurdles and market saturation, leading to fluctuating prices.

Recent Developments: The company has been focusing on streamlining operations and cutting costs to achieve profitability. This includes closing unprofitable operations and focusing on its core markets.

Future Outlook: The future for Canopy Growth looks promising as it continues to explore opportunities in new markets, especially in the U.S., pending federal legalization.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 2021280
Jan 202278
Apr 20245
Future (2025)4
Table for Canopy Growth


Overview: OrganiGram Holdings Inc. is a Canadian company that specializes in producing high-quality medical and recreational cannabis. It is known for its use of organic growth practices and has a strong focus on the Canadian market.

Historical Stock Performance: Like many in the sector, OrganiGram’s stock experienced highs in the early days of Canadian legalization but has been affected by the same oversupply and regulatory issues impacting the industry.

Recent Developments: OrganiGram has invested heavily in research and development to create new products and improve its cultivation techniques, which could help in gaining a competitive edge.

Future Outlook: The company is well-positioned to benefit from regulatory changes that favor high-quality, organic products, particularly in markets with a strong preference for such products.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 20214.5
Jan 20226.1
Apr 20241.07
Future (2025)2-4
Table for OrganiGram

Cronos Group

Overview: Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across five continents. The company is known for its ambitious international growth strategies and significant investment from Altria Group, a major player in the tobacco industry.

Historical Stock Performance: Cronos experienced rapid stock price increases due to initial excitement about international expansion but has faced declines amid broader market challenges.

Recent Developments: The company has been focusing on increasing efficiency and expanding its product line, particularly in cannabinoid-enhanced products.

Future Outlook: Cronos Group’s strategic partnerships and international presence position it uniquely to capitalize on new market openings and regulatory changes worldwide.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 20219.1
Jan 20223.5
Apr 20242.1
Future (2025)5-7
Table Cronos Group

Syn Biotic SE

Overview: Syn Biotic SE is a German investment firm focusing on the cannabis industry, including both recreational and medicinal sectors. The company pursues aggressive growth through acquisitions and strategic investments.

Historical Stock Performance: Syn Biotic SE’s stock has shown gradual growth, influenced by the evolving regulatory landscape in Europe regarding cannabis.

Recent Developments: The company has continued to expand its portfolio through strategic acquisitions, strengthening its position in the market.

Future Outlook: With ongoing changes in cannabis legislation in Europe, Syn Biotic SE is positioned to potentially benefit from new market opportunities.

Historical Prices and Future Price Predictions

DateHistorical Price (EUR)Future Price Prediction (EUR)
Jan 2021
Jan 202229
Apr 20243
Future (2025)15.00
Table Syn Biotic SE


Overview: Aurora Cannabis is a leader in the global cannabis market, known for its production of high-quality medical marijuana.

Historical Stock Performance: Aurora has experienced significant price fluctuations, reflecting the volatile nature of the cannabis industry.

Recent Developments: Aurora has been focusing on cost reduction and improving operational efficiencies to stabilize its financial position.

Future Outlook: The company aims to leverage advancements in cannabis research and global market expansions to boost its growth.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 202175
Jan 202248
Apr 20245.1
Future (2025)9.00
Table Aurora

Jazz Pharmaceuticals

Overview: Jazz Pharmaceuticals is a biopharmaceutical company with a strong focus on sleep disorders and cancer, along with an active interest in the cannabis sector through GW Pharmaceuticals acquisition.

Historical Stock Performance: Jazz Pharmaceuticals has shown a robust performance, thanks largely to its successful product portfolio and strategic acquisitions.

Recent Developments: Expansion into cannabinoid-based therapeutics has opened new revenue streams for the company.

Future Outlook: Jazz is expected to continue its growth trajectory, driven by strong product launches and integration of cannabis-based medicines.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 2021156.00
Jan 2022142.00
Apr 2024125.00
Future (2025)170.00
Table Jazz Pharmaceuticals

Innovative Industrial Properties

Overview: Innovative Industrial Properties is a real estate investment trust (REIT) specializing in the acquisition, ownership, and management of industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities.

Historical Stock Performance: The company’s stock performance has mirrored the growth and challenges in the cannabis industry, with fluctuations driven by market sentiment and regulatory changes.

Recent Developments: Innovative Industrial Properties continues to expand its portfolio by acquiring properties in key markets, maintaining a focus on long-term growth.Future Outlook: The outlook for Innovative Industrial Properties is cautiously optimistic as it relies on the expanding legalization of cannabis across the United States and the subsequent demand for regulated cannabis facilities.

Green Thumb Industries

Overview: Green Thumb Industries is a cannabis producer and retailer operating across the United States with a portfolio of branded cannabis products. The company focuses on consumer packaged goods and owns numerous dispensaries under the RISE brand.

Historical Stock Performance: Green Thumb’s stock has seen significant growth, reflective of its aggressive expansion and strong market presence.

Recent Developments: The company continues to expand its retail footprint and product offerings, maintaining robust financial health and operational efficiency.

Future Outlook: With the potential reclassification of cannabis at the federal level and ongoing state-level legalizations, Green Thumb is positioned to capitalize on new market opportunities.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 202122.00
Jan 202226.00
Apr 202415.00
Future (2025)15.50
Table Green Thumb Industries

Curaleaf Holdings

Overview: Curaleaf Holdings is a leading international provider of consumer products in cannabis, operating an integrated network of medical and wellness cannabis facilities throughout the United States.

Historical Stock Performance: Curaleaf’s performance has been bolstered by its extensive market penetration and strategic acquisitions, making it a major player in the cannabis industry.

Recent Developments: Curaleaf has focused on expanding its operations into new states and enhancing its product lines, particularly in high-margin derivatives and branded retail products.

Future Outlook: The company is expected to continue its growth trajectory supported by expanding legalization and increasing acceptance of cannabis for medical and recreational use.

Tilray Brands

Overview: Tilray Brands, Inc. is a global leader in cannabis research, cultivation, production, and distribution. The company has made significant strides in expanding its product offerings and international presence.

Historical Stock Performance: Tilray’s stock has experienced significant volatility, reflective of the broader challenges and opportunities within the cannabis industry.

Recent Developments: Tilray continues to grow through strategic mergers and increasing its production capabilities.

Future Outlook: The company aims to strengthen its position in the global cannabis market through innovations and expanding market access.

Historical Prices and Future Price Predictions

DateHistorical Price (USD)Future Price Prediction (USD)
Jan 202117.00
Jan 20226.00
Apr 20241.78
Future (2025)2.00 – 4.00
Table Tilray Brands


Overview: Altria Group, Inc. is a giant in the tobacco industry, known for its iconic Marlboro brand, with strategic investments in the cannabis sector through Cronos Group.

Historical Stock Performance: Altria has maintained stable performance with consistent dividend payouts, supported by its strong brand portfolio.

Recent Developments: Altria’s investment in cannabis through Cronos aims to capitalize on the evolving U.S. cannabis legislation.

Future Outlook: Altria plans to diversify further into reduced-risk products and cannabis, adapting to shifting consumer preferences.

Philip Morris

Overview: Philip Morris International is focused on developing smoke-free products and has shown interest in the cannabis sector as part of its long-term strategy to diversify.

Historical Stock Performance: The company has seen growth due to strong international sales of its smoke-free product line.

Recent Developments: Continued focus on IQOS, its heat-not-burn product, and exploration of opportunities in cannabis.

Future Outlook: Philip Morris is investing in technology and innovation to lead the smoke-free product market and is positioning to enter cannabis markets upon favorable legislative changes.

For more accurate and updated information, please refer directly to financial news platforms and stock analysis resources.

Investment Considerations

Investing in cannabis stocks involves both opportunities and risks:

  • Opportunities:
    • Growth Potential: As legalization spreads globally, the market for cannabis is expected to grow, providing significant opportunities for companies in the sector.
    • Diversification: Cannabis stocks can diversify an investment portfolio, offering exposure to a new and expanding industry.
  • Risks:
    • Regulatory Challenges: The legal landscape for cannabis is still evolving, and changes in regulations can have abrupt and substantial impacts on stock prices.
    • Market Volatility: As shown in the historical price data, cannabis stocks are highly volatile and can fluctuate widely in short periods.

Investors should consider their risk tolerance and investment horizon when investing in this sector, and possibly consult with a financial advisor to align these stocks with their long-term financial goals.


The cannabis industry continues to evolve rapidly, presenting both opportunities and challenges for investors. The companies discussed in this article represent a diverse range of players in the market, from producers and distributors to real estate investment trusts and tobacco giants with investments in cannabis.

While the sector has shown significant growth potential, it also faces regulatory hurdles and market volatility. Investors interested in entering this market should conduct thorough research, consider their risk tolerance, and stay informed about regulatory developments.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *